Clinical Trial Update: A Study of YZJ-4729 Tartrate Injection for the Treatment of Pain After Abdominal Surgery [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating YZJ-4729 Tartrate Injection for pain management after abdominal surgery is active but not currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pain

Drugs mentioned

• YZJ-4729 Tartrate Injection (YZJ-4729 tartrate)

Snippet

Sponsor: Shanghai Haiyan Pharmaceutical Technology Co., Ltd. | Conditions: Pain | Phase 3 | Status: ACTIVE_NOT_RECRUITING